Magnetic Resonance Imaging
Volume 26, Issue 1 , Pages 26-34 , January 2008

Lesion T2 relaxation times and volumes predict the response of malignant breast lesions to neoadjuvant chemotherapy

Received 23 October 2006 ,Revised 3 April 2007 ,Accepted 21 April 2007.

References 

  1. Wasser K, Klein SK, Fink C, Junkermann H, Sinn HP, Zuna I, et al. Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution. Eur Radiol. 2003;13:80–87
  2. Huang YM, Majumdar S, Genant HK, Chan WP, Sharma KR, Yu P, et al. Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular-dystrophy. J Magn Reson Imaging. 1994;4:59–64
  3. Mosher TJ, Dardzinski BJ, Smith MB. Human articular cartilage: influence of aging and early symptomatic degeneration on the spatial variation of T2 — preliminary findings at 3 T. Radiology. 2000;214:259–266
  4. Woermann FG, Steiner H, Barker GJ, Bartlett PA, Elger CE, Duncan JS, et al. A fast FLAIR dual-echo technique for hippocampal T2 relaxometry: first experiences in patients with temporal lobe epilepsy. J Magn Reson Imaging. 2001;13:547–552
  5. Liney GP, Turnbull LW, Lowry M, Turnbull LS, Knowles AJ, Horsman A. In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI. Magn Reson Imaging. 1997;15:1177–1186
  6. Altbach MI, Outwater EK, Trouard TP, Krupinski EA, Theilmann RJ, Stopeck AT, et al. Radial fast spin-echo method for T2-weighted imaging and T2 mapping of the liver. J Magn Reson Imaging. 2002;16:179–189
  7. Bloch P, Lenkinski RE, Buhle EL, Hendrix R, Bryer M, McKenna WG. The use of T2-distribution to study tumor extent and heterogeneity in head and neck-cancer. Magn Reson Imaging. 1991;9:205–211
  8. Braunschweiger PG. Effect of cyclophosphamide on the pathophysiology of RIF-1 solid tumors. Cancer Res. 1988;48:4206–4210
  9. Duvvuri U, Poptani H, Feldman M, Nadal-Desbarats L, Gee MS, Lee WMF, et al. Quantitative T1ρ magnetic resonance imaging of RIF-1 tumors in vivo: detection of early response to cyclophosphamide therapy. Cancer Res. 2001;61:7747–7753
  10. Pickles MD, Gibbs P, Lowry M, Turnbull LW. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging. 2006;24:843–847
  11. Manton DJ, Chaturvedi A, Hubbard A, Lind M, Lowry M, Maraveyas A, et al. Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy. Br J Cancer. 2006;94:427–435
  12. Partridge SC, Esserman LJ, Newitt DC, Hylton NM. Assessing the value of early MR measurements for predicting response to neoadjuvant treatment in locally advanced breast cancer. Proc ISMRM. 2001;9:2320
  13. Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Tripathy D, Wolverton DS, et al. MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. Am J Roentgenol. 2005;184:1774–1781
  14. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000;92:205–216
  15. Liney GP, Knowles AJ, Manton DJ, Turnbull LW, Blackband SJ, Horsman A. Comparison of conventional single echo and multi-echo sequences with a fast spin-echo sequence for quantitative T2 mapping: application to the prostate. J Magn Reson Imaging. 1996;6:603–607
  16. Hurd RE, Gurr D, Sailasuta N. Proton spectroscopy without water suppression: the oversampled J-resolved experiment. Magn Reson Med. 1998;40:343–347
  17. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;i:307–310
  18. Denis F, Sbiez-Bourcier AV, Chapiron C, Arbion F, Bodyd G, Brunereau L. Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer. Eur J Surg Oncol. 2004;30:1069–1076
  19. Londero V, Bazzocchi M, Del Frate C, Puglisi F, Di Loreto C, Francescutti G, et al. Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol. 2004;14:1371–1379
  20. Pickles MD, Lowry M, Manton DJ, Gibbs P, Turnbull LW. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat. 2005;91:1–10
  21. Merchant TE, Thelissen GRP, de Graaf PW, Nieuwenhuizen CWEA, Kievit HCE, den Otter W. Application of a mixed imaging sequence for MR imaging characterization of human breast disease. Acta Radiol. 1993;34:356–361
  22. Jagannathan NR, Singh M, Govindaraju V, Raghunathan P, Coshic O, Julka PK, et al. Volume localized in vivo proton MR spectroscopy of breast carcinoma: variation of water–fat ratio in patients receiving chemotherapy. NMR in Biomed. 1998;11:414–422

PII: S0730-725X(07)00262-7

doi: 10.1016/j.mri.2007.04.002

Magnetic Resonance Imaging
Volume 26, Issue 1 , Pages 26-34 , January 2008

Article Tools

* Image Usage & Resolution